Randomized study of adjuvant immunotherapy with autologous tumor cells and BCG in renal cancer. 1993

E Galligioni, and M Francini, and M Quaia, and A Carbone, and A Spada, and C Sacco, and D Favaro, and M Santarosa, and G Carmignani, and D Di Donna
Gruppo Oncologico Cooperativo del Nord-Est (GOCCNE), Centro di Riferimento Oncologico, Aviano, Italy.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses
D016233 Immunotherapy, Active Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as BCG vaccine and Corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system. Immune RNA Manipulation,Vaccine Therapy,Active Immunotherapy,Therapy, Vaccine,Active Immunotherapies,Immune RNA Manipulations,Immunotherapies, Active,Manipulation, Immune RNA,Manipulations, Immune RNA,RNA Manipulation, Immune,RNA Manipulations, Immune,Therapies, Vaccine,Vaccine Therapies

Related Publications

E Galligioni, and M Francini, and M Quaia, and A Carbone, and A Spada, and C Sacco, and D Favaro, and M Santarosa, and G Carmignani, and D Di Donna
June 1996, Cancer,
E Galligioni, and M Francini, and M Quaia, and A Carbone, and A Spada, and C Sacco, and D Favaro, and M Santarosa, and G Carmignani, and D Di Donna
January 1989, Journal of surgical oncology,
E Galligioni, and M Francini, and M Quaia, and A Carbone, and A Spada, and C Sacco, and D Favaro, and M Santarosa, and G Carmignani, and D Di Donna
January 2017, Oncoimmunology,
E Galligioni, and M Francini, and M Quaia, and A Carbone, and A Spada, and C Sacco, and D Favaro, and M Santarosa, and G Carmignani, and D Di Donna
August 1983, Archives of otolaryngology (Chicago, Ill. : 1960),
E Galligioni, and M Francini, and M Quaia, and A Carbone, and A Spada, and C Sacco, and D Favaro, and M Santarosa, and G Carmignani, and D Di Donna
January 1997, Journal of surgical oncology,
E Galligioni, and M Francini, and M Quaia, and A Carbone, and A Spada, and C Sacco, and D Favaro, and M Santarosa, and G Carmignani, and D Di Donna
August 2022, The Journal of clinical investigation,
E Galligioni, and M Francini, and M Quaia, and A Carbone, and A Spada, and C Sacco, and D Favaro, and M Santarosa, and G Carmignani, and D Di Donna
April 1979, Cancer,
E Galligioni, and M Francini, and M Quaia, and A Carbone, and A Spada, and C Sacco, and D Favaro, and M Santarosa, and G Carmignani, and D Di Donna
March 2005, Vaccine,
E Galligioni, and M Francini, and M Quaia, and A Carbone, and A Spada, and C Sacco, and D Favaro, and M Santarosa, and G Carmignani, and D Di Donna
July 1985, Gan to kagaku ryoho. Cancer & chemotherapy,
E Galligioni, and M Francini, and M Quaia, and A Carbone, and A Spada, and C Sacco, and D Favaro, and M Santarosa, and G Carmignani, and D Di Donna
February 1982, American journal of clinical oncology,
Copied contents to your clipboard!